Results for tag: "Imidocarb"

The Imidocarb market is a segment of the Animal Pharmaceuticals industry. Imidocarb is an antiprotozoal drug used to treat a variety of parasitic infections in animals. It is used to treat diseases such as babesiosis, ehrlichiosis, and leishmaniasis. Imidocarb is administered orally or intravenously, depending on the severity of the infection. It is also used to prevent the spread of certain diseases, such as babesiosis, in animals. Imidocarb is a widely used drug in the Animal Pharmaceuticals industry, as it is effective in treating a variety of parasitic infections. It is also relatively safe for animals, with few side effects. Some companies in the Imidocarb market include Merial, Boehringer Ingelheim, Elanco, and Virbac. Show Less Read more